ID FIG4_YEAST Reviewed; 879 AA. AC P42837; D6W0M2; DT 01-NOV-1995, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1995, sequence version 1. DT 27-MAR-2024, entry version 169. DE RecName: Full=Polyphosphoinositide phosphatase; DE EC=3.1.3.-; DE AltName: Full=Factor-induced gene 4 protein; DE AltName: Full=Phosphatidylinositol 3,5-bisphosphate 5-phosphatase; GN Name=FIG4; OrderedLocusNames=YNL325C; ORFNames=N0330; OS Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast). OC Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes; OC Saccharomycetales; Saccharomycetaceae; Saccharomyces. OX NCBI_TaxID=559292; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, SUBCELLULAR LOCATION, AND RP MUTAGENESIS OF GLY-519. RX PubMed=11950935; DOI=10.1091/mbc.01-10-0498; RA Gary J.D., Sato T.K., Stefan C.J., Bonangelino C.J., Weisman L.S., RA Emr S.D.; RT "Regulation of Fab1 phosphatidylinositol 3-phosphate 5-kinase pathway by RT Vac7 protein and Fig4, a polyphosphoinositide phosphatase family member."; RL Mol. Biol. Cell 13:1238-1251(2002). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=S288c / FY1676; RX PubMed=7645347; DOI=10.1002/yea.320110606; RA Maftahi M., Nicaud J.-M., Levesque H., Gaillardin C.; RT "Sequencing analysis of a 15.4 kb fragment of yeast chromosome XIV RT identifies the RPD3, PAS8 and KRE1 loci, five new open reading frames."; RL Yeast 11:567-572(1995). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC 204508 / S288c; RX PubMed=9169873; RA Philippsen P., Kleine K., Poehlmann R., Duesterhoeft A., Hamberg K., RA Hegemann J.H., Obermaier B., Urrestarazu L.A., Aert R., Albermann K., RA Altmann R., Andre B., Baladron V., Ballesta J.P.G., Becam A.-M., RA Beinhauer J.D., Boskovic J., Buitrago M.J., Bussereau F., Coster F., RA Crouzet M., D'Angelo M., Dal Pero F., De Antoni A., del Rey F., Doignon F., RA Domdey H., Dubois E., Fiedler T.A., Fleig U., Floeth M., Fritz C., RA Gaillardin C., Garcia-Cantalejo J.M., Glansdorff N., Goffeau A., RA Gueldener U., Herbert C.J., Heumann K., Heuss-Neitzel D., Hilbert H., RA Hinni K., Iraqui Houssaini I., Jacquet M., Jimenez A., Jonniaux J.-L., RA Karpfinger-Hartl L., Lanfranchi G., Lepingle A., Levesque H., Lyck R., RA Maftahi M., Mallet L., Maurer C.T.C., Messenguy F., Mewes H.-W., Moestl D., RA Nasr F., Nicaud J.-M., Niedenthal R.K., Pandolfo D., Pierard A., RA Piravandi E., Planta R.J., Pohl T.M., Purnelle B., Rebischung C., RA Remacha M.A., Revuelta J.L., Rinke M., Saiz J.E., Sartorello F., RA Scherens B., Sen-Gupta M., Soler-Mira A., Urbanus J.H.M., Valle G., RA Van Dyck L., Verhasselt P., Vierendeels F., Vissers S., Voet M., RA Volckaert G., Wach A., Wambutt R., Wedler H., Zollner A., Hani J.; RT "The nucleotide sequence of Saccharomyces cerevisiae chromosome XIV and its RT evolutionary implications."; RL Nature 387:93-98(1997). RN [4] RP GENOME REANNOTATION. RC STRAIN=ATCC 204508 / S288c; RX PubMed=24374639; DOI=10.1534/g3.113.008995; RA Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R., RA Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S., RA Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.; RT "The reference genome sequence of Saccharomyces cerevisiae: Then and now."; RL G3 (Bethesda) 4:389-398(2014). RN [5] RP FUNCTION, CATALYTIC ACTIVITY, COFACTOR, INTERACTION WITH VAC14, SUBCELLULAR RP LOCATION, AND MUTAGENESIS OF GLY-519. RX PubMed=14528018; DOI=10.1091/mbc.e03-05-0297; RA Rudge S.A., Anderson D.M., Emr S.D.; RT "Vacuole size control: regulation of PtdIns(3,5)P2 levels by the vacuole- RT associated Vac14-Fig4 complex, a PtdIns(3,5)P2-specific phosphatase."; RL Mol. Biol. Cell 15:24-36(2004). RN [6] RP LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS]. RX PubMed=14562106; DOI=10.1038/nature02046; RA Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N., RA O'Shea E.K., Weissman J.S.; RT "Global analysis of protein expression in yeast."; RL Nature 425:737-741(2003). RN [7] RP FUNCTION, AND MUTAGENESIS OF ASP-469 AND GLY-519. RX PubMed=16492811; DOI=10.1083/jcb.200512105; RA Duex J.E., Tang F., Weisman L.S.; RT "The Vac14p-Fig4p complex acts independently of Vac7p and couples PI3,5P2 RT synthesis and turnover."; RL J. Cell Biol. 172:693-704(2006). RN [8] RP MUTAGENESIS OF ILE-59. RX PubMed=17572665; DOI=10.1038/nature05876; RA Chow C.Y., Zhang Y., Dowling J.J., Jin N., Adamska M., Shiga K., RA Szigeti K., Shy M.E., Li J., Zhang X., Lupski J.R., Weisman L.S., RA Meisler M.H.; RT "Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and RT patients with CMT4J."; RL Nature 448:68-72(2007). RN [9] RP IDENTIFICATION IN THE PI(3,5)P2 REGULATORY COMPLEX, FUNCTION, AND RP SUBCELLULAR LOCATION. RX PubMed=19037259; DOI=10.1038/emboj.2008.248; RA Jin N., Chow C.Y., Liu L., Zolov S.N., Bronson R., Davisson M., RA Petersen J.L., Zhang Y., Park S., Duex J.E., Goldowitz D., Meisler M.H., RA Weisman L.S.; RT "VAC14 nucleates a protein complex essential for the acute interconversion RT of PI3P and PI(3,5)P(2) in yeast and mouse."; RL EMBO J. 27:3221-3234(2008). RN [10] RP IDENTIFICATION IN THE PI(3,5)P2 REGULATORY COMPLEX, AND SUBCELLULAR RP LOCATION. RX PubMed=18653468; DOI=10.1091/mbc.e08-04-0405; RA Botelho R.J., Efe J.A., Teis D., Emr S.D.; RT "Assembly of a Fab1 phosphoinositide kinase signaling complex requires the RT Fig4 phosphoinositide phosphatase."; RL Mol. Biol. Cell 19:4273-4286(2008). RN [11] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-829, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200; RA Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.; RT "A multidimensional chromatography technology for in-depth phosphoproteome RT analysis."; RL Mol. Cell. Proteomics 7:1389-1396(2008). CC -!- FUNCTION: The PI(3,5)P2 regulatory complex regulates both the synthesis CC and turnover of phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2). CC Major enzyme required for hyperosmotic shock-induced turnover of CC PtdIns(3,5)P2 and requires VAC14 for this function. In vivo, mediates CC turnover of PtdIns(3,5)P2 at the vacuole membrane necessary for CC vacuolar size control. In vitro, catalyzes the removal of phosphate CC from the fifth hydroxyl of the myo-inositol ring of CC phosphatidylinositol 3,5-bisphosphate. {ECO:0000269|PubMed:11950935, CC ECO:0000269|PubMed:14528018, ECO:0000269|PubMed:16492811, CC ECO:0000269|PubMed:19037259}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,5- CC bisphosphate) + H2O = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo- CC inositol-3-phosphate) + phosphate; Xref=Rhea:RHEA:32955, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:57923, CC ChEBI:CHEBI:58088; Evidence={ECO:0000269|PubMed:14528018}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000269|PubMed:14528018}; CC -!- SUBUNIT: Component of the PI(3,5)P2 regulatory complex, composed of CC ATG18, FIG4, FAB1, VAC14 and VAC7. VAC14 nucleates the assembly of the CC complex and serves as a scaffold. {ECO:0000269|PubMed:18653468, CC ECO:0000269|PubMed:19037259}. CC -!- INTERACTION: CC P42837; P34756: FAB1; NbExp=4; IntAct=EBI-28407, EBI-6754; CC P42837; Q06708: VAC14; NbExp=7; IntAct=EBI-28407, EBI-27189; CC -!- SUBCELLULAR LOCATION: Vacuole membrane {ECO:0000269|PubMed:11950935, CC ECO:0000269|PubMed:14528018, ECO:0000269|PubMed:18653468, CC ECO:0000269|PubMed:19037259}; Peripheral membrane protein CC {ECO:0000269|PubMed:11950935, ECO:0000269|PubMed:14528018, CC ECO:0000269|PubMed:18653468, ECO:0000269|PubMed:19037259}. CC Note=Localized to the limiting membrane of the vacuole. Localization CC requires VAC14 and FAB1. CC -!- MISCELLANEOUS: Present with 339 molecules/cell in log phase SD medium. CC {ECO:0000269|PubMed:14562106}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; Z46259; CAA86373.1; -; Genomic_DNA. DR EMBL; Z71601; CAA96256.1; -; Genomic_DNA. DR EMBL; BK006947; DAA10238.1; -; Genomic_DNA. DR PIR; S55864; S55864. DR RefSeq; NP_014074.1; NM_001183163.1. DR AlphaFoldDB; P42837; -. DR SMR; P42837; -. DR BioGRID; 35516; 127. DR ComplexPortal; CPX-3088; PAS complex. DR IntAct; P42837; 3. DR MINT; P42837; -. DR STRING; 4932.YNL325C; -. DR iPTMnet; P42837; -. DR MaxQB; P42837; -. DR PaxDb; 4932-YNL325C; -. DR PeptideAtlas; P42837; -. DR EnsemblFungi; YNL325C_mRNA; YNL325C; YNL325C. DR GeneID; 855392; -. DR KEGG; sce:YNL325C; -. DR AGR; SGD:S000005269; -. DR SGD; S000005269; FIG4. DR VEuPathDB; FungiDB:YNL325C; -. DR eggNOG; KOG1888; Eukaryota. DR GeneTree; ENSGT00550000074943; -. DR HOGENOM; CLU_003016_0_1_1; -. DR InParanoid; P42837; -. DR OMA; KRKCCAH; -. DR OrthoDB; 996872at2759; -. DR BioCyc; MetaCyc:MONOMER3O-86; -. DR BioCyc; YEAST:MONOMER3O-86; -. DR BioGRID-ORCS; 855392; 0 hits in 10 CRISPR screens. DR PRO; PR:P42837; -. DR Proteomes; UP000002311; Chromosome XIV. DR RNAct; P42837; Protein. DR GO; GO:0000329; C:fungal-type vacuole membrane; IDA:SGD. DR GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central. DR GO; GO:0034399; C:nuclear periphery; IDA:SGD. DR GO; GO:0070772; C:PAS complex; IDA:SGD. DR GO; GO:0043813; F:phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; IDA:SGD. DR GO; GO:1903100; P:1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process; NAS:ComplexPortal. DR GO; GO:0046856; P:phosphatidylinositol dephosphorylation; IDA:SGD. DR GO; GO:0010511; P:regulation of phosphatidylinositol biosynthetic process; NAS:ComplexPortal. DR InterPro; IPR043573; Fig4-like. DR InterPro; IPR002013; SAC_dom. DR PANTHER; PTHR45738; POLYPHOSPHOINOSITIDE PHOSPHATASE; 1. DR PANTHER; PTHR45738:SF5; POLYPHOSPHOINOSITIDE PHOSPHATASE; 1. DR Pfam; PF02383; Syja_N; 1. DR PROSITE; PS50275; SAC; 1. PE 1: Evidence at protein level; KW Hydrolase; Membrane; Phosphoprotein; Reference proteome; Vacuole. FT CHAIN 1..879 FT /note="Polyphosphoinositide phosphatase" FT /id="PRO_0000209742" FT DOMAIN 166..528 FT /note="SAC" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00183" FT REGION 761..879 FT /note="Required for vacuolar localization" FT MOD_RES 829 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18407956" FT MUTAGEN 59 FT /note="I->T: Defective activation of FAB1." FT /evidence="ECO:0000269|PubMed:17572665" FT MUTAGEN 469 FT /note="D->N: Partially defective in both hyperosmotic FT shock-induced PtdIns(3,5)P2 elevation and turnover." FT /evidence="ECO:0000269|PubMed:16492811" FT MUTAGEN 519 FT /note="G->R: In FIG4-1; loss of catalytic activity in FT vitro. Almost 3-fold increase in PtdIns(3,5)P2 level in FT vivo. Partially defective in both hyperosmotic FT shock-induced PtdIns(3,5)P2 elevation and turnover." FT /evidence="ECO:0000269|PubMed:11950935, FT ECO:0000269|PubMed:14528018, ECO:0000269|PubMed:16492811" SQ SEQUENCE 879 AA; 101746 MW; 872B3231104185FA CRC64; MNNDAMEHTL GGGILTTSGS KQRKTSKFVM GKYTLYETKD RMYIVGSNKR ETMFRILEID LTVPRGELTV LEDNVFFTRN EIMNVLASLE EATEDGLHKK ITGYGLLGFI KFTCWYYLIM VTKYSQVAVI GGHGIYHIDG IDIIPITNNY KKPEKSSDEA RLLNIFKDLD LTKTFYFSYT YDITNTLQTN ILREKLKAVD RCDITIPCGI TDYNEMFVWN NNLLSPIFAC IDTVFDWFQC IIHGFIDQVN VSVLGKSIYI TLIARRSHHF AGARFLKRGV NNKGHVANEV ETEQIVTDMI LTPFHQPGNG FFDSDRYTSF VQHRGSIPLY WTQDASNLTT KPPIRINVVD PFFSPAALHF DNLFQRYGGG TIQILNLIKT KEKTPRETKL LWEFEQCIDY LNEFLPTLKK LDYTSWDMSR ASKQDGQGVI EFLEKYAVNT VTTTGIFHNG PDFASTKIQE GICRSNCIDC LDRTNAAQFV IGKRALGCQL KSLGIIDNSY LEYDSDIVNI LTELFHDLGD TIALQYGGSH LVNTMETYRK INQWSSHSRD MIESIKRFYS NSFVDAQRQD AINLFLGHYS WREGFPSLWE MNTDFYLHNA YSLNMPKRSY IHWWNDYNIK SVKELINEEL IATGNDVTRE KIIKNVRGYP GAFDNYWNEY YLPRSVTWIR DLFAYNMNST RRYHNALSKQ DKAMSPFTSR KQSWLNNKLK MITSSKSLEK AEGRVVETTD LDRDTSPKQE LELYEHYLHI ISDRSQKLEE KMNSFSYSKY PIFISHESSE IPPMRKVIGE PLVDIAEDFT DVYDDDDDGD DENDEMTTEA LLIAPDHVSV DEKFYEKVLN VDDYKPALDD YSAVIHIKPD NLQLYRDLCF SKDIQLDFQ //